Results - Announcements
Biocon Ltd share price gained 0.19% to Rs 344.0 after the company's net profit tumbled by 58.55% to Rs 56.7 crore, while revenue from operations improved marginally 1.24% to Rs 4345.0 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, rising 5.14%. It has marginally improved by 2.03% over last one week and moved up slightly by 1.77% in last one month while the market capitalization of Biocon Ltd has slipped by 2.27% and 20% in the same period respectively.
Profit before tax (PBT) of Biocon Ltd stood at Rs 54.8 crore in Q3 FY26, nosediving by 68.01% year-on-year, and tumbling by 57.05% quarter-on-quarter. EBITDA came in at Rs 796 crore, gaining 7.27% YoY and easing 0.47% sequentially.
Total expenses posted a minor rise of 2.12% to Rs 4121.8 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1669.0 crore, going up by 17.20% YoY, while employee benefits expense was at Rs 891.9 crore, slipping by 3.90% YoY.
For the TTM ended FY26, revenue from operations rose 11.48% to Rs 16779.9 crore, while net profit witnessed a sharp fall of 74.20% to Rs 368.8 crore, compared to previous TTM. EBITDA soared by 222680% to Rs 3112.8 crore, and PBT tanked by 76.26% to Rs 447.9 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 1994.0 crore in FY26, as against Rs 4061.2 crore in FY25.
Biocon Ltd nosedived by 9.53% in last one year, significantly underperforming the benchmark BSE Sensex which has softened by 7.38% during the same period.